Patents by Inventor Scott Ludecker

Scott Ludecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11839390
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: December 12, 2023
    Assignee: MISONIX, LLC
    Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
  • Patent number: 11147570
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: October 19, 2021
    Assignee: MISONIX, INCORPORATED
    Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
  • Publication number: 20210228225
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Application
    Filed: April 13, 2021
    Publication date: July 29, 2021
    Inventors: PAUL MIKUS, SCOTT ISOLA, DAN VOIC, SCOTT LUDECKER, ALEXANDER DARIAN
  • Patent number: 10973537
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: April 13, 2021
    Assignee: MISONIX, INCORPORATED
    Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
  • Publication number: 20190167285
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Application
    Filed: February 6, 2019
    Publication date: June 6, 2019
    Inventors: Paul MIKUS, Scott ISOLA, Dan VOIC, Scott LUDECKER, Alexander DARIAN
  • Patent number: 10299809
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: May 28, 2019
    Assignee: MISONIX, INCORPORATED
    Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
  • Publication number: 20190015123
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Application
    Filed: September 10, 2018
    Publication date: January 17, 2019
    Inventors: PAUL MIKUS, Scott ISOLA, Dan VOIC, Scott LUDECKER, Alexander DARIAN
  • Patent number: 10092308
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: October 9, 2018
    Assignee: MISONIX, INC.
    Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
  • Publication number: 20160128707
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Application
    Filed: November 5, 2015
    Publication date: May 12, 2016
    Inventors: PAUL MIKUS, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
  • Publication number: 20160128708
    Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.
    Type: Application
    Filed: November 12, 2015
    Publication date: May 12, 2016
    Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian